Market Place
Sourcing Support
All News #Library
FDA Issues Form 483 to Zhejiang Hisun Pharmaceuticals
30 Mar 2022 //
FDA
FDA Issues Form 483 to Zhejiang Hisun Pharmaceuticals [8.11.17 483]
30 Mar 2022 //
FDA
Zhejiang Hisun Pharmaceutical on Health Canada Inspection list
25 Jun 2020 //
HEALTH CANADA
Zhejiang Hisun Pharmaceutical Co., Ltd. (Yantou Campus) Fail EDQM Campus
30 Jul 2019 //
EDQM
Zhejiang Hisun Pharmaceutical Co., Ltd – East Campus Fails EDQM Inspection
30 Jul 2019 //
EDQM
Zhejiang Hisun Pharmaceutical Co. Ltd. On Health Canada Inspection List
11 Jan 2017 //
HEALTH CANADA
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Waisha Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical, Co (East Factory Campus) Fails EDQM Inspection
19 Sep 2016 //
EDQM
Zhejiang Hisun Pharmaceutical Co., Ltd on USFDA Import Alert
18 Feb 2016 //
FDA
Zhejiang Hisun Pharmaceutical receives warning letter due to cGMP deviations
31 Dec 2015 //
FDA
Zhejiang Hisun on FDA Import Alert List
10 Sep 2015 //
Zhejiang Hisun Pharma drugs quarantined due to data integrity concerns
17 Jun 2015 //
HEALTHY CANADIANS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.